PDE4B: Difference between revisions

Jump to navigation Jump to search
m (Bot: HTTP→HTTPS)
imported>Citation bot
m (Alter: url, issue. Add: bibcode. Formatted dashes. You can use this bot yourself. Report bugs here. | Headbomb)
 
Line 2: Line 2:
'''cAMP-specific 3',5'-cyclic phosphodiesterase 4B''' is an [[enzyme]] that in humans is encoded by the ''PDE4B'' [[gene]].<ref name="entrez">{{cite web | title = Entrez Gene: PDE4B phosphodiesterase 4B, cAMP-specific (phosphodiesterase E4 dunce homolog, Drosophila)| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=5142| accessdate = }}</ref>
'''cAMP-specific 3',5'-cyclic phosphodiesterase 4B''' is an [[enzyme]] that in humans is encoded by the ''PDE4B'' [[gene]].<ref name="entrez">{{cite web | title = Entrez Gene: PDE4B phosphodiesterase 4B, cAMP-specific (phosphodiesterase E4 dunce homolog, Drosophila)| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=5142| accessdate = }}</ref>


This gene is a member of the type IV, cyclic AMP (cAMP)-specific, cyclic nucleotide [[phosphodiesterase]] (PDE) family. Cyclic nucleotides are important second messengers that regulate and mediate a number of [[Cell (biology)|cell]]ular responses to extracellular signals, such as [[hormone]]s, [[light]], and [[neurotransmitter]]s. The [[cyclic nucleotide phosphodiesterase]]s (PDEs) regulate the cellular concentrations of cyclic nucleotides and thereby play a role in signal transduction. This gene encodes a protein that specifically hydrolyzes [[Cyclic adenosine monophosphate|cAMP]]. Alternate transcriptional splice variants, encoding different [[isoforms]], have been characterized.<ref name="entrez" /><ref>{{Cite book|title = Behavioral Neurobiology of Schizophrenia and Its Treatment|url = https://books.google.com/books?id=udlELa8_6aoC&pg=PA643&dq=pde4b+gene&hl=en&sa=X&ei=Zw5WVZL2MIuUNpXqgJgI&ved=0CCsQ6AEwAQ#v=onepage&q=pde4b%20gene&f=false|publisher = Springer Science & Business Media|date = 2010-08-19|isbn = 9783642137174|first = Neal R.|last = Swerdlow}}</ref>
This gene is a member of the type IV, cyclic AMP (cAMP)-specific, cyclic nucleotide [[phosphodiesterase]] (PDE) family. Cyclic nucleotides are important second messengers that regulate and mediate a number of [[Cell (biology)|cell]]ular responses to extracellular signals, such as [[hormone]]s, [[light]], and [[neurotransmitter]]s. The [[cyclic nucleotide phosphodiesterase]]s (PDEs) regulate the cellular concentrations of cyclic nucleotides and thereby play a role in signal transduction. This gene encodes a protein that specifically hydrolyzes [[Cyclic adenosine monophosphate|cAMP]]. Alternate transcriptional splice variants, encoding different [[isoforms]], have been characterized.<ref name="entrez" /><ref>{{Cite book|title = Behavioral Neurobiology of Schizophrenia and Its Treatment|url = https://books.google.com/?id=udlELa8_6aoC&pg=PA643&dq=pde4b+gene#v=onepage&q=pde4b%20gene&f=false|publisher = Springer Science & Business Media|date = 2010-08-19|isbn = 9783642137174|first = Neal R.|last = Swerdlow}}</ref>


==Clinical relevance==
==Clinical relevance==
Line 10: Line 10:
== Inhibitors ==
== Inhibitors ==


[[AN2728]], a [[boron]]-containing drug candidate that as of 2015 was under development by [[Anacor]] Pharmaceuticals for the topical treatment of [[psoriasis]] and [[atopic dermatitis]] (atopic eczema).<ref name=Anacor>Anacor [http://www.anacor.com/an2728.php AN2728 at Anacor website] Page accessed May 15, 2015</ref><ref name=Nazarian>{{cite journal | vauthors = Nazarian R, Weinberg JM | title = AN-2728, a PDE4 inhibitor for the potential topical treatment of psoriasis and atopic dermatitis | journal = Current Opinion in Investigational Drugs | volume = 10 | issue = 11 | pages = 1236–42 | date = Nov 2009 | pmid = 19876791 }}</ref><ref name=Moustafa>{{cite journal | vauthors = Moustafa F, Feldman SR | date = May 2014 | title = A review of phosphodiesterase-inhibition and the potential role for phosphodiesterase 4-inhibitors in clinical dermatology | url = http://escholarship.org/uc/item/2hx1m6kv#page-1 | journal = Dermatol Online J. | volume = 20 | issue = 5| page = 22608 | pmid = 24852768 }}</ref> mainly acting on PDE4B.<ref name=Moustafa/>
[[AN2728]], a [[boron]]-containing drug candidate that as of 2015 was under development by [[Anacor]] Pharmaceuticals for the topical treatment of [[psoriasis]] and [[atopic dermatitis]] (atopic eczema).<ref name=Anacor>Anacor [http://www.anacor.com/an2728.php AN2728 at Anacor website] Page accessed May 15, 2015</ref><ref name=Nazarian>{{cite journal | vauthors = Nazarian R, Weinberg JM | title = AN-2728, a PDE4 inhibitor for the potential topical treatment of psoriasis and atopic dermatitis | journal = Current Opinion in Investigational Drugs | volume = 10 | issue = 11 | pages = 1236–42 | date = Nov 2009 | pmid = 19876791 }}</ref><ref name=Moustafa>{{cite journal | vauthors = Moustafa F, Feldman SR | date = May 2014 | title = A review of phosphodiesterase-inhibition and the potential role for phosphodiesterase 4-inhibitors in clinical dermatology | url = http://escholarship.org/uc/item/2hx1m6kv#page-1 | journal = Dermatol. Online J. | volume = 20 | issue = 5| page = 22608 | pmid = 24852768 }}</ref> mainly acting on PDE4B.<ref name=Moustafa/>


== References ==
== References ==
Line 17: Line 17:
== Further reading ==
== Further reading ==
{{refbegin|33em}}
{{refbegin|33em}}
* {{cite journal | vauthors = Szpirer C, Szpirer J, Rivière M, Swinnen J, Vicini E, Conti M | title = Chromosomal localization of the human and rat genes (PDE4D and PDE4B) encoding the cAMP-specific phosphodiesterases 3 and 4 | journal = Cytogenetics and Cell Genetics | volume = 69 | issue = 1-2 | pages = 11–4 | year = 1995 | pmid = 7835077 | doi = 10.1159/000133927 }}
* {{cite journal | vauthors = Szpirer C, Szpirer J, Rivière M, Swinnen J, Vicini E, Conti M | title = Chromosomal localization of the human and rat genes (PDE4D and PDE4B) encoding the cAMP-specific phosphodiesterases 3 and 4 | journal = Cytogenetics and Cell Genetics | volume = 69 | issue = 1–2 | pages = 11–4 | year = 1995 | pmid = 7835077 | doi = 10.1159/000133927 }}
* {{cite journal | vauthors = Bolger GB, Rodgers L, Riggs M | title = Differential CNS expression of alternative mRNA isoforms of the mammalian genes encoding cAMP-specific phosphodiesterases | journal = Gene | volume = 149 | issue = 2 | pages = 237–44 | date = Nov 1994 | pmid = 7958996 | doi = 10.1016/0378-1119(94)90155-4 }}
* {{cite journal | vauthors = Bolger GB, Rodgers L, Riggs M | title = Differential CNS expression of alternative mRNA isoforms of the mammalian genes encoding cAMP-specific phosphodiesterases | journal = Gene | volume = 149 | issue = 2 | pages = 237–44 | date = Nov 1994 | pmid = 7958996 | doi = 10.1016/0378-1119(94)90155-4 }}
* {{cite journal | vauthors = Milatovich A, Bolger G, Michaeli T, Francke U | title = Chromosome localizations of genes for five cAMP-specific phosphodiesterases in man and mouse | journal = Somatic Cell and Molecular Genetics | volume = 20 | issue = 2 | pages = 75–86 | date = Mar 1994 | pmid = 8009369 | doi = 10.1007/BF02290677 }}
* {{cite journal | vauthors = Milatovich A, Bolger G, Michaeli T, Francke U | title = Chromosome localizations of genes for five cAMP-specific phosphodiesterases in man and mouse | journal = Somatic Cell and Molecular Genetics | volume = 20 | issue = 2 | pages = 75–86 | date = Mar 1994 | pmid = 8009369 | doi = 10.1007/BF02290677 }}
Line 25: Line 25:
* {{cite journal | vauthors = Huston E, Lumb S, Russell A, Catterall C, Ross AH, Steele MR, Bolger GB, Perry MJ, Owens RJ, Houslay MD | title = Molecular cloning and transient expression in COS7 cells of a novel human PDE4B cAMP-specific phosphodiesterase, HSPDE4B3 | journal = The Biochemical Journal | volume = 328 | issue = Pt 2 | pages = 549–58 | date = Dec 1997 | pmid = 9371714 | pmc = 1218954 | doi =  10.1042/bj3280549}}
* {{cite journal | vauthors = Huston E, Lumb S, Russell A, Catterall C, Ross AH, Steele MR, Bolger GB, Perry MJ, Owens RJ, Houslay MD | title = Molecular cloning and transient expression in COS7 cells of a novel human PDE4B cAMP-specific phosphodiesterase, HSPDE4B3 | journal = The Biochemical Journal | volume = 328 | issue = Pt 2 | pages = 549–58 | date = Dec 1997 | pmid = 9371714 | pmc = 1218954 | doi =  10.1042/bj3280549}}
* {{cite journal | vauthors = Ma D, Wu P, Egan RW, Billah MM, Wang P | title = Phosphodiesterase 4B gene transcription is activated by lipopolysaccharide and inhibited by interleukin-10 in human monocytes | journal = Molecular Pharmacology | volume = 55 | issue = 1 | pages = 50–7 | date = Jan 1999 | pmid = 9882697 | doi =  }}
* {{cite journal | vauthors = Ma D, Wu P, Egan RW, Billah MM, Wang P | title = Phosphodiesterase 4B gene transcription is activated by lipopolysaccharide and inhibited by interleukin-10 in human monocytes | journal = Molecular Pharmacology | volume = 55 | issue = 1 | pages = 50–7 | date = Jan 1999 | pmid = 9882697 | doi =  }}
* {{cite journal | vauthors = Secchiero P, Zella D, Curreli S, Mirandola P, Capitani S, Gallo RC, Zauli G | title = Pivotal role of cyclic nucleoside phosphodiesterase 4 in Tat-mediated CD4+ T cell hyperactivation and HIV type 1 replication | journal = Proceedings of the National Academy of Sciences of the United States of America | volume = 97 | issue = 26 | pages = 14620–5 | date = Dec 2000 | pmid = 11114167 | pmc = 18968 | doi = 10.1073/pnas.011512398 }}
* {{cite journal | vauthors = Secchiero P, Zella D, Curreli S, Mirandola P, Capitani S, Gallo RC, Zauli G | title = Pivotal role of cyclic nucleoside phosphodiesterase 4 in Tat-mediated CD4+ T cell hyperactivation and HIV type 1 replication | journal = Proceedings of the National Academy of Sciences of the United States of America | volume = 97 | issue = 26 | pages = 14620–5 | date = Dec 2000 | pmid = 11114167 | pmc = 18968 | doi = 10.1073/pnas.011512398 | bibcode = 2000PNAS...9714620S }}
* {{cite journal | vauthors = Zauli G, Milani D, Mirandola P, Mazzoni M, Secchiero P, Miscia S, Capitani S | title = HIV-1 Tat protein down-regulates CREB transcription factor expression in PC12 neuronal cells through a phosphatidylinositol 3-kinase/AKT/cyclic nucleoside phosphodiesterase pathway | journal = FASEB Journal | volume = 15 | issue = 2 | pages = 483–91 | date = Feb 2001 | pmid = 11156964 | doi = 10.1096/fj.00-0354com }}
* {{cite journal | vauthors = Zauli G, Milani D, Mirandola P, Mazzoni M, Secchiero P, Miscia S, Capitani S | title = HIV-1 Tat protein down-regulates CREB transcription factor expression in PC12 neuronal cells through a phosphatidylinositol 3-kinase/AKT/cyclic nucleoside phosphodiesterase pathway | journal = FASEB Journal | volume = 15 | issue = 2 | pages = 483–91 | date = Feb 2001 | pmid = 11156964 | doi = 10.1096/fj.00-0354com }}
* {{cite journal | vauthors = Moon E, Lee R, Near R, Weintraub L, Wolda S, Lerner A | title = Inhibition of PDE3B augments PDE4 inhibitor-induced apoptosis in a subset of patients with chronic lymphocytic leukemia | journal = Clinical Cancer Research | volume = 8 | issue = 2 | pages = 589–95 | date = Feb 2002 | pmid = 11839681 | doi =  }}
* {{cite journal | vauthors = Moon E, Lee R, Near R, Weintraub L, Wolda S, Lerner A | title = Inhibition of PDE3B augments PDE4 inhibitor-induced apoptosis in a subset of patients with chronic lymphocytic leukemia | journal = Clinical Cancer Research | volume = 8 | issue = 2 | pages = 589–95 | date = Feb 2002 | pmid = 11839681 | doi =  }}
Line 33: Line 33:
* {{cite journal | vauthors = Smith PG, Wang F, Wilkinson KN, Savage KJ, Klein U, Neuberg DS, Bollag G, Shipp MA, Aguiar RC | title = The phosphodiesterase PDE4B limits cAMP-associated PI3K/AKT-dependent apoptosis in diffuse large B-cell lymphoma | journal = Blood | volume = 105 | issue = 1 | pages = 308–16 | date = Jan 2005 | pmid = 15331441 | doi = 10.1182/blood-2004-01-0240 }}
* {{cite journal | vauthors = Smith PG, Wang F, Wilkinson KN, Savage KJ, Klein U, Neuberg DS, Bollag G, Shipp MA, Aguiar RC | title = The phosphodiesterase PDE4B limits cAMP-associated PI3K/AKT-dependent apoptosis in diffuse large B-cell lymphoma | journal = Blood | volume = 105 | issue = 1 | pages = 308–16 | date = Jan 2005 | pmid = 15331441 | doi = 10.1182/blood-2004-01-0240 }}
* {{cite journal | vauthors = Ballif BA, Villén J, Beausoleil SA, Schwartz D, Gygi SP | title = Phosphoproteomic analysis of the developing mouse brain | journal = Molecular & Cellular Proteomics | volume = 3 | issue = 11 | pages = 1093–101 | date = Nov 2004 | pmid = 15345747 | doi = 10.1074/mcp.M400085-MCP200 }}
* {{cite journal | vauthors = Ballif BA, Villén J, Beausoleil SA, Schwartz D, Gygi SP | title = Phosphoproteomic analysis of the developing mouse brain | journal = Molecular & Cellular Proteomics | volume = 3 | issue = 11 | pages = 1093–101 | date = Nov 2004 | pmid = 15345747 | doi = 10.1074/mcp.M400085-MCP200 }}
* {{cite journal | vauthors = Millar JK, Pickard BS, Mackie S, James R, Christie S, Buchanan SR, Malloy MP, Chubb JE, Huston E, Baillie GS, Thomson PA, Hill EV, Brandon NJ, Rain JC, Camargo LM, Whiting PJ, Houslay MD, Blackwood DH, Muir WJ, Porteous DJ | title = DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signaling | journal = Science | volume = 310 | issue = 5751 | pages = 1187–91 | date = Nov 2005 | pmid = 16293762 | doi = 10.1126/science.1112915 }}
* {{cite journal | vauthors = Millar JK, Pickard BS, Mackie S, James R, Christie S, Buchanan SR, Malloy MP, Chubb JE, Huston E, Baillie GS, Thomson PA, Hill EV, Brandon NJ, Rain JC, Camargo LM, Whiting PJ, Houslay MD, Blackwood DH, Muir WJ, Porteous DJ | title = DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signaling | journal = Science | volume = 310 | issue = 5751 | pages = 1187–91 | date = Nov 2005 | pmid = 16293762 | doi = 10.1126/science.1112915 | bibcode = 2005Sci...310.1187M }}
* {{cite journal | vauthors = Kimura K, Wakamatsu A, Suzuki Y, Ota T, Nishikawa T, Yamashita R, Yamamoto J, Sekine M, Tsuritani K, Wakaguri H, Ishii S, Sugiyama T, Saito K, Isono Y, Irie R, Kushida N, Yoneyama T, Otsuka R, Kanda K, Yokoi T, Kondo H, Wagatsuma M, Murakawa K, Ishida S, Ishibashi T, Takahashi-Fujii A, Tanase T, Nagai K, Kikuchi H, Nakai K, Isogai T, Sugano S | title = Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes | journal = Genome Research | volume = 16 | issue = 1 | pages = 55–65 | date = Jan 2006 | pmid = 16344560 | pmc = 1356129 | doi = 10.1101/gr.4039406 }}
* {{cite journal | vauthors = Kimura K, Wakamatsu A, Suzuki Y, Ota T, Nishikawa T, Yamashita R, Yamamoto J, Sekine M, Tsuritani K, Wakaguri H, Ishii S, Sugiyama T, Saito K, Isono Y, Irie R, Kushida N, Yoneyama T, Otsuka R, Kanda K, Yokoi T, Kondo H, Wagatsuma M, Murakawa K, Ishida S, Ishibashi T, Takahashi-Fujii A, Tanase T, Nagai K, Kikuchi H, Nakai K, Isogai T, Sugano S | title = Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes | journal = Genome Research | volume = 16 | issue = 1 | pages = 55–65 | date = Jan 2006 | pmid = 16344560 | pmc = 1356129 | doi = 10.1101/gr.4039406 }}
{{refend}}
{{refend}}
{{PDB Gallery|geneid=5142}}
{{PDB Gallery|geneid=5142}}
{{Esterases}}
{{Esterases}}

Latest revision as of 22:30, 29 December 2018

VALUE_ERROR (nil)
Identifiers
Aliases
External IDsGeneCards: [1]
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

n/a

n/a

RefSeq (protein)

n/a

n/a

Location (UCSC)n/an/a
PubMed searchn/an/a
Wikidata
View/Edit Human

cAMP-specific 3',5'-cyclic phosphodiesterase 4B is an enzyme that in humans is encoded by the PDE4B gene.[1]

This gene is a member of the type IV, cyclic AMP (cAMP)-specific, cyclic nucleotide phosphodiesterase (PDE) family. Cyclic nucleotides are important second messengers that regulate and mediate a number of cellular responses to extracellular signals, such as hormones, light, and neurotransmitters. The cyclic nucleotide phosphodiesterases (PDEs) regulate the cellular concentrations of cyclic nucleotides and thereby play a role in signal transduction. This gene encodes a protein that specifically hydrolyzes cAMP. Alternate transcriptional splice variants, encoding different isoforms, have been characterized.[1][2]

Clinical relevance

Altered activity of this protein has been associated with schizophrenia and bipolar disorder.[1] PDE4B is believed to be the PDE4 subtype involved in the antipsychotic effects of PDE4 inhibitors such as rolipram.[3] PDE4B is involved in dopamine-associated and stress-related behaviours.[4] It has also recently been found to modulate cognition, as reduction in PDE4B activity improves memory and long-term plasticity in mouse models, possibly supporting further therapeutic applications.[5]

Inhibitors

AN2728, a boron-containing drug candidate that as of 2015 was under development by Anacor Pharmaceuticals for the topical treatment of psoriasis and atopic dermatitis (atopic eczema).[6][7][8] mainly acting on PDE4B.[8]

References

  1. 1.0 1.1 1.2 "Entrez Gene: PDE4B phosphodiesterase 4B, cAMP-specific (phosphodiesterase E4 dunce homolog, Drosophila)".
  2. Swerdlow, Neal R. (2010-08-19). Behavioral Neurobiology of Schizophrenia and Its Treatment. Springer Science & Business Media. ISBN 9783642137174.
  3. Porteous DJ, Millar JK, Brandon NJ, Sawa A (Dec 2011). "DISC1 at 10: connecting psychiatric genetics and neuroscience". Trends in Molecular Medicine. 17 (12): 699–706. doi:10.1016/j.molmed.2011.09.002. PMC 3253483. PMID 22015021.
  4. Francis, SH; Conti, M; Houslay, MD, eds. (2011). Phosphodiesterases as Drug Targets (PDF). Handbook of Experimental Pharmacology. 204. Springer Berlin Heidelberg. doi:10.1007/978-3-642-17969-3. ISBN 978-3-642-17968-6.
  5. http://newsdaily.com/2015/08/scientists-researching-brain-disorders-create-super-clever-mice/
  6. Anacor AN2728 at Anacor website Page accessed May 15, 2015
  7. Nazarian R, Weinberg JM (Nov 2009). "AN-2728, a PDE4 inhibitor for the potential topical treatment of psoriasis and atopic dermatitis". Current Opinion in Investigational Drugs. 10 (11): 1236–42. PMID 19876791.
  8. 8.0 8.1 Moustafa F, Feldman SR (May 2014). "A review of phosphodiesterase-inhibition and the potential role for phosphodiesterase 4-inhibitors in clinical dermatology". Dermatol. Online J. 20 (5): 22608. PMID 24852768.

Further reading